Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti‐CD19 CAR‐T therapy: a case report-Reference-Cited by-同舟云学术

Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti‐CD19 CAR‐T therapy: a case report

Published:2021-08-04 Issue:4 Volume:2 Page:848-853
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Mackenzie Strachan¹²^ORCID,Shafat Manar¹,Roddy Harriet¹,Hyare Harpreet³⁴,Neill Lorna³,Marzolini Maria A. V.³,Gilhooley Michael⁵,Marafioti Teresa⁶,Kara Eleanna⁷,Sanchez Emilie⁸,Rees Jeremy⁹,Lynch David S.⁹,Thomson Kirsty³,Ardeshna Kirit M.³,Laurence Arian³,Peggs Karl S.¹³,O'Reilly Maeve³^ORCID,Roddie Claire¹³

Affiliation:

1. UCL Cancer Institute Paul O'Gorman Building University College London London UK

2. UCL Great Ormond Street Institute of Child Health University College London London UK

3. Department of Haematology University College London Hospital NHS Foundation Trust London UK

4. Department of Radiology University College London Hospital NHS Foundation Trust London UK

5. The Institute of Ophthalmology University College London Bath Street London UK

6. Department of Histopathology University College London 60 Whitfield Street London UK

7. Department of Neuropathology National Hospital of Neurology and Neurosurgery University College London Hospital NHS Foundation Trust Queen Square London UK

8. Department of Virology University College London Hospital NHS Foundation Trust London UK

9. Institute of Neurology National Hospital of Neurology and Neurosurgery University College London Queen Square London UK

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.274

Reference20 articles.

1. Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma;Wudhikarn K;Blood Cancer J,2020

2. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease

3. Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine

4. Allogeneic BK Virus–Specific T Cells for Progressive Multifocal Leukoencephalopathy

5. Increased Program Cell Death–1 Expression on T Lymphocytes of Patients With Progressive Multifocal Leukoencephalopathy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progressive multifocal leukoencephalopathy after CAR-T cell therapy;Bone Marrow Transplantation;2024-09-10

2. Overview of infectious complications among CAR T- cell therapy recipients;Frontiers in Oncology;2024-07-03

3. Blood–brain barrier breakdown, central nervous system cell damage, and infiltrated T cells as major adverse effects in CAR-T-related deaths: a literature review;Frontiers in Medicine;2024-01-08

4. High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T‐cell therapy for large B‐cell lymphoma;HemaSphere;2024-01

5. Combined treatment with allogeneic Epstein–Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report;Therapeutic Advances in Neurological Disorders;2024-01